Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Toxoplasma gondii infection in the United States, 1999–2000.Emerg Infect Dis. 2003; ([serial online] [2009 September].) (Available at:) (Accessed October 22, 2009.)
- Risk factors for Toxoplasma gondii infection in the United States.Clin Infect Dis. 2009; 49: 878-884
- Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection.N Engl J Med. 1994; 330: 1858-1863
- Infection and stillbirth.Semin Fetal Neonatal Med. 2009; 14: 182-189
- Preventing congenital toxoplasmosis.MMWR Recomm Rep. 2000; 49: 57-75
- Management of Toxoplasma gondii infection during pregnancy.Clin Infect Dis. 2008; 47: 554-566
- Diagnosis and management of toxoplasmosis.Clin Perinatol. 2005; 32: 705-726
- Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy.J Clin Microbiol. 1989; 27: 2133-2135
- Confirmatory serologic testing for acute toxoplasmosis and the rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers.Am J Obstet Gynecol. 2001; 184: 140-145
- Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA).Clin Chem. 2005; 51: 2415-2418
- Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women.Eur J Clin Microbiol Infect Dis. 2006; 25: 687-693
- Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis.Obstet Gynecol. 2001; 97: 296-300
- Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters.Am J Obstet Gynecol. 1999; 181: 843-847
- Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.Mem Inst Oswaldo Cruz. 2009; 104 ([Online]): 389-392
- Use of antiprotozoan and anthelmintic drugs during pregnancy: side-effects and contra-indications.J Infect. 1992; 25: 1-9
- Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.Drug Saf. 2007; 30: 481-501
- Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.J Infect. 2006; 52: e55-e57
- Toxoplasmosis-related knowledge and practices among pregnant women in the United States.Infect Dis Obstet Gynecol. 2003; 11: 139-145
- Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy.J Womens Health. 2009; 18: 1187-1193
- Prevention of toxoplasmosis during pregnancy–an epidemiologic survey over 22 consecutive years.J Perinat Med. 2004; 32: 211-214
- The role of parvovirus B19 in anaplastic crisis and erythema infectiosum (fifth disease).J Infect Dis. 1986; 154: 383-393
- Human parvovirus B19: historical and clinical review.Rev Infect Dis. 1988; 10: 1005-1011
- Human parvovirus in pregnancy.Obstet Gynecol. 1988; 72: 733-738
- Detection antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.J Clin Microbiol. 1986; 24: 522-526
- Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.BMJ. 1990; 300: 1166-1170
- Parvovirus B19 infection in fetal deaths.Clin Infect Dis. 2008; 47: 1519-1525
- Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction.Am J Obstet Gynecol. 1992; 167: 461-466
- The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia.Am J Obstet Gynecol. 2008; 198 (e1–4): 161
- Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of non-immune hydrops.J Clin Ultrasound. 2009; 37: 385-388
- Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians.Am J Obstet Gynecol. 1998; 79: 985-988
- Intrauterine management of fetal parvovirus B19 infection.Ultrasound Obstet Gynecol. 1999; 13: 161-166
- Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion.J Ultrasound Med. 1998; 17: 547-550
- Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.Obstet Gynecol. 2007; 109: 42-47
- Long-term outcome of children following maternal human parvovirus B19 infection.Obstet Gynecol. 1998; 91: 125-128
- Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.Rev Med Virol. 2007; 17: 253-276
- Institute of Medicine Committee to Study Priorities for Vaccine Development. Vaccines for the 21st Century: a tool for decision making.in: Stratton K.R. Durch J.S. Lawrence R.S. National Academy Press, Washington, DC2000: 460
- Cytomegalovirus.in: Jeffries D.J. Hudson C.N. Viral infections in obstetrics and gynecology. Arnold, New York1999: 35-36
- The outcome of congenital cytomegalovirus in relation to maternal antibody status.N Engl J Med. 1992; 326: 663-667
- Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality.Pediatr Infect Dis J. 1992; 11: 93-99
- Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?.J Pediatr. 1999; 135: 60-64
- Congenital cytomegalovirus infection following primary maternal infection in the third trimester.BJOG. 2008; 115: 830-835
- Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease.Br J Obstet Gynaecol. 2005; 112: 166-172
- Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk.Obstet Gynecol. 2000; 95: 881-888
- Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus and clinical outcome.JAMA. 1986; 256: 1904-1908
- Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot and nine commercially available assays.Clin Diagn Lab Immunol. 1997; 4: 483-486
- Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection.Hum Immunol. 2004; 65: 410-415
- Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects.Clin Diagn Lab Immunol. 1997; 4: 469-473
- Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnancy women at risk of transmitting cytomegalovirus.Viral Immunol. 2000; 13: 137-141
- Cordocentesis. Obstet Gynecol Clin North Am. 1988; 15: 283-301
- Prenatal diagnosis of fetal primary cytomegalovirus infection.Obstet Gynecol. 1997; 89: 763-767
- Prenatal diagnosis of symptomatic congenital cytomegalovirus infection.Am J Obstet Gynecol. 2000; 183: 476-482
- The megalovirus.Ultrasound Obstet Gynecol. 1998; 12: 151-153
- Ultrasound prediction of symptomatic congenital cytomegalovirus infection.Am J Obstet Gynecol. 2008; 198 (e1–7): 380
- Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.J Clin Virol. 2006; 35: 216-220
- Evaluation of virologic procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum.J Med Virol. 1996; 50: 9-15
- Passive immunization during pregnancy for congenital cytomegalovirus infection.N Engl J Med. 2005; 353: 1350-1362
- Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.J Perinatol. 2008; 25: 74-76
- Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis.Am J Obstet Gynecol. 2009; 201 (e1–7): 466
Article info
Publication history
Published online: June 16, 2010
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
